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Lipid lactate peakAbstract Choline and lipid lactate peaks elevated in a number of intracranial space occupying
lesions, in endemic area tuberculosis should be considered. Choline peak along with lipid lactate
elevation is non-speciﬁc and can be seen in a number of other conditions like high-grade gliomas,
Metastases, lymphomas and demyelinating disorders. We present a case of 45 year old gentle man
known case chest tuberculosis on treatment default presenting with multiple intracranial lesions
showing lipid–choline elevation.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
In MR spectroscopy (MRS), neuro metabolite NAA is consid-
ered as a good metabolite (as it represents neuronal health),
choline is considered as a bad metabolite (as it is seen in
tumors) and lipid lactate doublet as an ugly metabolite (as it
is seen in necrotic tumors), however this is not always
true as numerous exceptions exist (1–3). In an endemic area,
cerebral tuberculomas have to be considered as one of the dif-ferential diagnosis when elevated choline–lipid lactate peak is
detected (1). We describe a case of multiple intracranial lesions
which showed lipid–choline peaks. The patient was a defaulter
on ATT and because of it we made initial diagnosis of multiple
tuberculomas. There were a number of factors that were con-
fusing which lead to the bias and MRS left us puzzling without
giving us further lead in this case. (Elevated choline and lipid
peaks with NAA/choline ratio less than 2.)2. Case report
A 45 year gentleman, presented with the history of headache,
vomiting and low grade fever of 15 days duration. He was dull
for the last 5 days. He received treatment for pulmonary tuber-
culosis 1 year back but did not complete it. On examination, he
had altered sensorium, however was obeying commands.
Fig. 1 Chest X ray is showing the right upper lobe ﬁbrosis and
right hilar lesion.
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operative for sensory examination. Fundus showed bilateral
papilledema, EOM full, pupils were bilateral equal and react-
ing to light. Facial nerves were normal. All deep tendon
reﬂexes were normal. Plantars were extensor on the left side
and ﬂexor on the right side. Blood investigations were normal
except for a moderately raised erythrocyte sedimentation rate
(ESR-36 mm in the ﬁrst hour). Mantoux test was positive.
Chest radiograph showed hilar shadow on right and ﬁbrotic
changes in the right upper zone (Fig. 1). CT was performed
on emergency which showed multiple isodense opacities with
perilesional edema in cerebrum and cerebellum, the largest
one was in the right frontal lobe (Fig. 2). MRI was performed
on 3T GE HDXT 750W MR machine and it showed multiple
ring lesions in supratentorial and infratentorial location, the
largest lesion in the right frontal lobe was hypointense on T1Fig. 2 Plain CT scan showing heterogeneous iso-hyderdense lesionand was showing mixed signal intensity with extensive perile-
sional edema on T2 (Fig. 3). MRS was performed. MR
spectroscopy was performed using multiple voxel technique
and intermediate TE (144 ms) spectral sampling in the center
of the lesion showed high lipid lactate and choline, at the
periphery choline peaks were more pronounced than lipid
peaks (Figs. 4 and 5). The choline/NAA ratio in the center
was 1.34 and at periphery it was 1.9. Lumbar puncture was
deferred because of poor compliance of the patient. In view
of clinical and past history a provisional diagnosis of tubercu-
losis was made and for establishing diagnosis biopsy was per-
formed and sent for histopathological evaluation (Fig. 6)
which conﬁrmed the larger lesion to be metastatic adenocarci-
noma (see Fig. 7).
3. Discussion
Magnetic resonance spectroscopy (MRS) detects biochemical
metabolites of tissue in vivo. (3) MRS is a useful adjunct to
routine conventional MR imaging. It is operator and inter-
preter dependent up to some extent, positioning of voxel is a
very important step in performing MRS, which if not accurate
will obtain contaminated or sub optimal spectra. Interpreter
requires an overall knowledge of the biochemical metabolites
and the possible differential diagnosis. It is difﬁcult to perform
MRS on smaller lesions as partial volume averaging will con-
taminate the spectra. Many disorders have overlapping MRS
features. Choline peak in brain MRS is a cell membrane mar-
ker and its elevation indicates high cellularity or cell destruc-
tion as seen in most neoplastic lesions, however can be seen
in infections (Tubercular and fungal infections) and inﬂamma-
tory disorders (demyelination) (1,3–5). Lipid lactate peak is
consistently seen with necrotic tumors, lymphomas and tuber-
culomas (1,3–9). Gupta et al have described that increased
choline along with the presence of lipid/lactate is a nonspeciﬁc
ﬁnding and may not be useful in the differentiation of tumors
from infective/inﬂammatory intracranial lesions (1). In our
case conventional MR imaging with T1 and T2 spin echo,
FLAIR, GRE sequences were equivocal as they could notin the right parietal region showing extensive vasogenic edema.
Fig. 3 (A) T1W sequence showing isointense lesion in the right frontal lobe with hypointense vasogenic edema and (B–F) T2W multiple
hyperintense lesions are seen in both frontal lobes and in cerebellum largest lesion is the right frontal lobe showing extensive vasogenic
edema and hyperintense T2 sequence showing heterogeneous signal intensity.
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Multivoxel MR Spectroscopy showed lipid–choline peak.
MRS in brain metastases shows prominent lipid lactate and
choline peaks with reduced NAA and creatinine peaks (10).
However this spectral formation is not ﬁnger print of metasta-
ses and there exists considerable overlap with other conditions.
Tuberculomas can be differentiated from metastases based on
T2W images (black lesion), however it is not fool proof as
different stages of tuberculomas look different on T2 (11).
As high grade glioma shows adjacent parenchymal invasion
choline elevation is seen in surrounding edema but not inFig. 4 Centre of lesion showing lipid lactate peak at 0.9 and 1.3 p
2.0 ppm.metastases (12). Lymphomas show homogenous enhancement,
lack of necrosis and show lactate elevation on MRS along with
lipid–choline peaks. Demyelinating diseases can be differenti-
ated from other causes of lipid–choline elevation by classical
acute history and presentation. Recent literature suggests that
metabolite ratios are more speciﬁc in distinguishing neoplastic
lesions from non-neoplastic pathologies and high grade neo-
plasms from low grade neoplasms (12,13). A high Cho/NAA
ratio (>2.5) is an indicator of a high-grade neoplasm, low
Cho/NAA ratio is attributed to low-grade neoplasm or nonne-
oplastic processes (13). Choline/creatinine ratio above 2.0 ispm and choline peak at 3.25 ppm, also note decreased NAA at
Fig. 7 (A) Sheets of tumor cells arranged in glandular and cribriform pattern, foci of necrosis also seen (H&E-100) and (B) tumor cells
arranged in glandular pattern and having vesicular nuclei with prominent nucleoli (H&E-400).
Fig. 5 Periphery of the lesion showing lipid lactate peak at 0.9 and 1.3 ppm and choline peak at 3.25 ppm, also note decreased NAA at
2.0 ppm. (choline peak is more pronounced at the periphery than in center).
Fig. 6 Right frontal lobe lesion – post surgical excision.
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line/NAA and choline/creatinine ratios were in low cellular
neoplastic/non-neoplastic range.
4. Conclusion
Attempt to comprehend MRS on the basis of summary points
(Good, bad and Ugly concept of metabolites) lacking eagle eye
vision while interpreting can lead to erroneous diagnosis and
thereby affecting the ﬁnal outcome. Choline peak along withlipid lactate elevation is a puzzle in MRS as it is found in a
number of conditions like high-grade gliomas, Metastases,
lymphomas tuberculomas, demyelinating disorders etc. To
solve this puzzle, one should read spectra under the light of
conventional MR imaging and clinical history and if any
doubt should not hesitate to perform biopsy.
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